Health News

Weight Doesn't Matter for IVF
For women with fertility issues, in vitro fertilization (IVF) is often a viable treatment. The success or failure of IVF does not seem to be influenced at all by the weight of the women, researchers have found.
Back Pain? Stretch It Out!
Need to find relief for the constant pain in your lower back? A new study recommends that you sign up for a stretching or yoga class. After a few weeks, you'll feel the difference.
Sepsis Drug Pulled
U.S. Food and Drug Administration officials announced that Eli Lily and Company have voluntarily pulled Xigris (drotrecogin alfa) from all markets because the medication failed to show increased survival for patients suffering from severe sepsis in a major study.
FDA approves Ferriprox
The U.S. Food and Drug Administration today approved Ferriprox ( deferiprone ) to treat patients with iron overload due to blood transfusions in patients with thalassemia , a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy.
HPV Vaccines now Recommended for Boys
Human papilloma virus (HPV) is no longer just a concern for girls and women. Boys and men are vulnerable to this virus that's known to cause a number of different cancers.
Stacking the Deck Against Breast Cancer
Breast cancer is not 100 percent preventable, no matter how vigilant someone is. However, there are plenty of things you can do to limit your risks.
Severe Depression Under-Treated
About 11 percent of Americans aged 12 and over take antidepressant medications. Yet only about one-third of severely depressed people are on such medication.
FDA Safety Communication: Chantix
The U.S. Food and Drug Administration (FDA) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix ( varenicline ).
Diet and Weight - Are There Lymphoma Risks?
What you eat today could impact your health 10 years from now. That's what's becoming increasingly clear in medical research, and a new study confirms this.
FDA Drug Safety Communication: Xigris
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that on October 25, 2011, Eli Lilly and Company announced a worldwide voluntary market withdrawal of Xigris [ drotrecogin alfa (activated)].